lifileucel - Robuta Search

https://www.pharmaceutical-technology.com/data-insights/lifileucel-iovance-biotherapeutics-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-259260&utm_campaign=recommended-articles-pi

Lifileucel by Iovance Biotherapeutics for Recurrent Head And Neck Squamous Cell Carcinoma:...

Lifileucel is under clinical development by Iovance Biotherapeutics and currently in Phase II for Recurrent Head And Neck Squamous Cell Carcinoma.

iovance biotherapeutics lifileucel recurrent head neck

https://pubmed.ncbi.nlm.nih.gov/33979178/

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Lifileucel demonstrated durable responses and addresses a major unmet need in patients with metastatic melanoma with limited treatment options after approved...

tumor infiltrating lymphocyte metastatic melanoma lifileucel therapy

https://www.pharmaceutical-technology.com/news/iovance-submits-lifileucel-bla-to-us-fda/

Iovance submits lifileucel BLA to US FDA - Pharmaceutical Technology

Iovance is pursuing accelerated approval in advanced melanoma for the tumour infiltrating lymphocyte (TIL) therapy.

us fda pharmaceutical technology iovance submits lifileucel